UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

Nature communications, 2021-10, Vol.12 (1), p.6012-6012, Article 6012

2021

Volltextzugriff (PDF)

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Nature medicine, 2021-02, Vol.27 (2), p.310-320

2021

Volltextzugriff (PDF)

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models

Breast cancer research : BCR, 2022-09, Vol.24 (1), p.63-12, Article 63

2022

Volltextzugriff (PDF)

A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes

Nature communications, 2018-06, Vol.9 (1), p.2311-13, Article 2311

2018

Volltextzugriff (PDF)

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

Breast cancer research : BCR, 2020-08, Vol.22 (1), p.87-87, Article 87

2020

Volltextzugriff (PDF)

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models

Breast cancer research : BCR, 2021-08, Vol.23 (1), p.82-20, Article 82

2021

Volltextzugriff (PDF)

Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer

Clinical cancer research, 2023-05, Vol.29 (10), p.1952-1968

2023

Volltextzugriff (PDF)

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma

Pathology, 2024-02, Vol.56, p.S70-S71

2024

Volltextzugriff (PDF)

Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-17-PS18-17

2021

Volltextzugriff (PDF)

Abstract PD9-01: Stromal mediators of lymphocyte exclusion and dysfunction in triple negative breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD9-01-PD9-01

2023

Volltextzugriff (PDF)

Using single cell genomics to change the treatment of lung cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20563-e20563

2019

Volltextzugriff (PDF)

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

Journal of Nuclear Medicine, 2013-06, Vol.54 (6), p.913-921

2013

Volltextzugriff (PDF)

Abstract PO5-01-09: Exploring cellular heterogeneity of localised breast cancers

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-01-09-PO5-01-09

2024

Volltextzugriff (PDF)

Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS2-03-GS2-03

2020

Volltextzugriff (PDF)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Clinical epigenetics, 2021-12, Vol.13 (1), p.226, Article 226

2021

Volltextzugriff (PDF)

Hedgehog inhibition impaired platinum response in high-grade serous ovarian cancer harboring high hedgehog ligand expression and mTOR pathway activation

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5583-5583

2017

Volltextzugriff (PDF)

Claudin-1 as a novel transcriptional target of hedgehog signaling and a predictor for outcome in breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1053-1053

2013

Volltextzugriff (PDF)

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC

NPJ precision oncology, 2019-08, Vol.3 (1), p.21, Article 21

2019

Volltextzugriff (PDF)

Review of: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Breast cancer online, 2008-01, Vol.11 (1), p.e2-e2, Article e2

Swarbrick, Alex

2008

Volltextzugriff (PDF)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

Circulating microRNAs associated with docetaxel-resistant castration resistant prostate cancer

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.44-44

2014

Volltextzugriff (PDF)

Antiprogestin Inhibition of Cell Cycle Progression in T-47D Breast Cancer Cells Is Accompanied by Induction of the Cyclin-Dependent Kinase Inhibitor p21

Molecular endocrinology (Baltimore, Md.), 1997-01, Vol.11 (1), p.54-66

1997

Volltextzugriff (PDF)

When it's VUCA, who do you call?

Training Journal, 2012-08, p.47

2012

Volltextzugriff (PDF)

Non-invasive detection of a small number of bioluminescent cancer cells in vivo

PloS one, 2010-02, Vol.5 (2), p.e9364-e9364

2010

Volltextzugriff (PDF)

Microbial decomposition of organic matter and wetting–drying promotes aggregation in artificial soil but porosity increases only in wet-dry condition

Geoderma, 2024-07, Vol.447, p.116924, Article 116924

2024

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models

A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models

Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma

Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer

Abstract PD9-01: Stromal mediators of lymphocyte exclusion and dysfunction in triple negative breast cancer

Using single cell genomics to change the treatment of lung cancer

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

Abstract PO5-01-09: Exploring cellular heterogeneity of localised breast cancers

Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Hedgehog inhibition impaired platinum response in high-grade serous ovarian cancer harboring high hedgehog ligand expression and mTOR pathway activation

Claudin-1 as a novel transcriptional target of hedgehog signaling and a predictor for outcome in breast cancer

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC

Review of: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer

Circulating microRNAs associated with docetaxel-resistant castration resistant prostate cancer

Antiprogestin Inhibition of Cell Cycle Progression in T-47D Breast Cancer Cells Is Accompanied by Induction of the Cyclin-Dependent Kinase Inhibitor p21

When it's VUCA, who do you call?

Non-invasive detection of a small number of bioluminescent cancer cells in vivo

Microbial decomposition of organic matter and wetting–drying promotes aggregation in artificial soil but porosity increases only in wet-dry condition

Suchergebnisse filtern